Implications of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response

Hematology, Transfusion and Cell Therapy

Volumn 43, Issue 1, 2021, Pages 58-64

  Aguilar Nascimento, José Eduardo ^a   Zampieri Filho, José Pedro ^b,c   Bordin, José O ^b,c  

^a CENTRO UNIVERSITÁRIO DE VÁRZEA GRANDE   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

Author keywords

Allogeneic transfusion; Colorectal cancer; Immunomodulation

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; ENDOGENOUS COMPOUND; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; HEMOGLOBIN; HISTAMINE; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGENIC AGENT; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SUPEROXIDE; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; APOPTOSIS; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; COLON CANCER; CYTOKINE RELEASE; CYTOTOXICITY; DISEASE FREE SURVIVAL; DOWN REGULATION; HEMOLYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LAPAROSCOPY; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; OPERATIVE BLOOD LOSS; OVERALL SURVIVAL; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; PREGNANCY; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; TH2 CELL;

EID: 85086169588     PISSN: 25311379     EISSN: 25311387     Source Type: Journal    
DOI: 10.1016/j.htct.2020.03.003     Document Type: Review

References (53)

1. Weinberg, B.A., Marshall, J.L., Salem, M.E., The growing challenge of young adults with colorectal cancer. Oncology 31:5 (2017), 381–389.
2. Ydy, L.R., Slhessarenko, N., de Aguilar-Nascimento, J.E., Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 31:10 (2007), 2044–2051.
3. Schiergens, T.S., Rentsch, M., Kasparek, M.S., Frenes, K., Jauch, K.W., Thasler, W.E., Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum 58:1 (2015), 74–82.
4. Cata, J.P., Wamg, H., Gottumukkala, V., Reuben, J., Sessler, D.I., Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anesthes 110 (2013), 690–701.
5. Mosmann, T.R., Kobie, J.J., Lee, F.E., Quataert, S.A., T helper cytokine patterns: defined subsets, random expression, and external modulation. Immunol Res 45 (2009), 173–184.
6. + regulatory T cells in the human immune system. Nat Rev Immunol 10 (2010), 490–500.
7. Blajchman, M.A., Bordin, J.O., Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1 (1994), 457–461.
8. Vamvakas, E.C., Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 16 (2002), 144–160.
9. Bordin, J.O., Heddle, N.M., Blajchman, M.A., Biologic effects of leukocytes present in transfused cellular blood products. Blood 84 (1994), 1703–1721.
10. Bordin, J.O., Bardossy, L., Blajchman, M.A., Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1 (1994), 344–348.
11. Kao, K.J., Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UV-B irradiated leukocytes. Blood 88 (1996), 4375–4382.
12. Jackman, R.P., Deng, X., Bolgiano, D., Utter, G.U., Schechterly, C., Lebeveda, M., et al. Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response. Transfusion 54 (2014), 672–680.
13. Clark, D.A., Gorczynski, R.M., Blajchman, M.A., Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecules and alloantigen. Transfusion 48 (2008), 214–221.
14. Reed, W., Lee, T.H., Norris, P.J., Transfusion-associated microchimerism: a new complication of blood transfusions in severely ill patients. Semin Hematol 44 (2007), 24–31.
15. Fresland, O., Ip, L.S.K., Storlien, A.S., Microchimerism in immune-competent patients related to the leukocyte content of transfused red blood cell concentrates. Transfus Apher Sci 31 (2004), 173–180.
16. Utter, G.H., Lee, T.H., Rivers, R.M., Montalvo, L., Wen, L., Chafets, D.M., et al. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 48 (2008), 1609–1615.
17. Kirkley, S.A., Cowles, J., Pellegrini, V.D. Jr., Blood transfusions and total joint replacement surgery: T-helper 2 cytokine secretion and clinical outcome. Transfus Med 8 (1998), 195–204.
18. Aslam, R., Speck, E.R., Kim, M., Freedman, J., Semple, J.W., Transfusion-related immunomodulation by platelets is dependent of their expression of MHC Class I molecules and is independent of white cells. Transfusion 48 (2008), 1778–1786.
19. Krensky, A.M., Clayberger, C., Structure of HLA molecules and immunosuppressive effects of HLA derived peptides. Int Rev Immunol 13 (1996), 173–185.
20. Ghio, M., Contini, P., Mazzei, C., Soluble HLA Class I, HLA Class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood 93 (1999), 1770–1777.
21. Hashimoto, M.N., Kimura, E.Y., Yamamoto, M., Bordin, J.O., Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusion. Transfusion 44 (2004), 158–163.
22. Ghio, M., Contini, P., Negrini, S., Mazzei, C., Zocchi, M.R., Poggi, A., Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion 51 (2011), 1567–1573.
23. Ghio, M., Contini, P., Ubezio, G., Ansaldi, F., Setti, M., Tripodi, G., Blood transfusions with high levels of containing soluble HLA-1 correlate with levels of soluble CD8 in recipients’ plasma: a new control factor in soluble HLA-1-mediate transfusion-modulated immunomodulation?. Blood Transfus 21 (2012), 1–4.
24. Nielsen, H.J., Reimert, C.M., Pedersen, A.N., Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 36 (1996), 960–965.
25. Shanwell, A., Kristiansson, M., Remberger, M., Ringden, O., Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 37 (1997), 678–684.
26. Bordin, J.O., Chiba, A.K., Carvalho, K.I., Takata, E.T., Falcão, R.P., Garcia, A.B., et al. The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients. Transfusion 39 (1999), 718–723.
27. Pereira, L.A., Baiocchi, O.C.G., Silva, J.N.K., Takata, E.T., Bordin, J.O., Regulatory CD4+ T lymphocytes frequency and cytokine profile following unmodified red cell transfusion in orthopedic patients. Br J Haematol 176:2 (2017), 327–330.
28. Baumgartner, J.M., Silliman, C.C., Moore, E.E., Banerjee, A., McCarter, M.D., Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 208 (2009), 110–119.
29. Baumgartner, J.M., Nydam, T.L., Clarke, J., Banerjee, A., Silliman, C.C., McCarter, M.D., Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interf Cytok Res 29 (2009), 333–338.
30. Hod, E.A., Zhang, N., Sokol, S.A., Wojczyk, B.S., Francis, R.O., Ansaldi, D., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 115 (2010), 4284–4292.
31. Hod, E.A., Brittenham, G.M., Billote, G.B., Francis, R.O., Ginzburg, Y.Z., Hendrickson, J.E., et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 118 (2011), 6675–6682.
32. Keir, A.K., McPhee, A.J., Andersen, C.C., Stark, M.J., Plasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant. Pediatr Res 73 (2013), 75–79.
33. Jackman, R.P., Utter, G.U., Muench, M.O., Heitman, J.W., Munz, M.M., Jackman, R.W., et al. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 52 (2012), 2533–2550.
34. Weiden, P.L., Bean, M.A., Schultz, P., Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 60 (1987), 870–874.
35. Sene, A., Jeacock, J., Robinson, C., Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer. Ann Royal College Surg Engl 75 (1993), 261–266.
36. Ghinea, R., Greenberg, R., White, I., Sacham-Shmueli, E., Mahagna, H., Avital, S., Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival. Tech Coloproctol 17:5 (2013), 549–554.
37. Meng, J., Lu, X.B., Tang, Y.X., Sun, G.P., Li, X., Yan, Y.F., et al. Effects of allogeneic blood transfusion in patients with stage II colon cancer. Asian Pac J Cancer Prev 14:1 (2013), 347–350.
38. Harlaar, J.J., Gosselink, M.P., Hop, W.C., Lange, J.F., Busch, O.R., Jeekel, H., Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial. Ann Surg 256:5 (2012), 681–686.
39. Busch, O.R., Hop, W.C., Hoynck van Papendrecht, M.A., Marquet, R.L., Jeekel, J., Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328:19 (1993), 1372–1376.
40. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies, Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:1 (2006), 198–208.
41. Engelbrecht, S., Wood, E.M., Cole-Sinclair, M.F., Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards. Med J Aust 199:6 (2013), 397–401.
42. Goodnough, L.T., Levy, J.H., Murphy, M.F., Concepts of blood transfusion in adults. Lancet 381:9880 (2013), 1845–1854.
43. Bracey, A.W., Radovancevic, R., Riggs, S.A., Houston, S., Cozart, H., Vaughn, W.K., et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion 39:10 (1999), 1070–1077.
44. Carson, J.L., Carless, P.A., Hébert, P.C., Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 309:1 (2013), 83–84.
45. Halabi, W.J., Jafari, M.D., Nguyen, V.Q., Carmichael, J.C., Mills, S., Pigazzi, A., et al. Blood transfusions in colorectal cancer surgery: incidence, outcomes, and predictive factors: an American College of Surgeons National Surgical Quality Improvement Program analysis. Am J Surg 206:6 (2013), 1024–1032.
46. Froman, J.P., Mathiason, M.A., Kallies, K.J., Bottner, W.A., Shapiro, S.B., The impact of an integrated transfusion reduction initiative in patients undergoing resection for colorectal cancer. Am J Surg 204:6 (2012), 944–950.
47. Mörner, M.E., Edgren, G., Martling, A., Gunnarsson, U., Egenvall, M., Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer – a Swedish cohort study. Int J Colorectal Dis 32:2 (2017), 223–232.
48. Wang, C.L., Qu, G., Xu, H.W., The short- and long-term outcomes of laparoscopic versus open surgery for colorectal cancer: a meta-analysis. Int J Colorectal Dis 29:3 (2014), 309–320.
49. Pang, Q.Y., An, R., Liu, H.L., Perioperative transfusion and the prognosis of colorectal cancer surgery: a systematic review and meta-analysis. World J Surg Oncol, 17(1), 2019, 7.
50. Mynster, T., Nielsen, H.J., The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 35:2 (2000), 212–217.
51. Mynster, T., Nielsen, H.J., Danish RANX05 Colorectal Cancer Study Group, Storage time of transfused blood and disease recurrence after colorectal cancer surgery. Dis Colon Rectum 44:7 (2001), 955–964.
52. Kekre, N., Mallick, R., Allan, D., Tinmouth, A., Tay, J., The impact of prolonged storage of red blood cells on cancer survival. PLoS One, 8(7), 2013, e68820.
53. Amri, R., Dinaux, A.M., Leijssen, L.G.J., Kunitake, H., Bordeianou, L.G., Berger, D.L., Do packed red blood cell transfusions really worsen oncologic outcomes in colon cancer?. Surgery 162:3 (2017), 586–591.